Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Yun Young | - |
dc.contributor.author | Park, Hee Ho | - |
dc.contributor.author | Park, Wooram | - |
dc.contributor.author | Kim, Hyelim | - |
dc.contributor.author | Jang, Jong Geol | - |
dc.contributor.author | Hong, Kyung Soo | - |
dc.contributor.author | Lee, Jae-Young | - |
dc.contributor.author | Seo, Hee Seung | - |
dc.contributor.author | Na, Dong Hee | - |
dc.contributor.author | Kim, Tae-Hyung | - |
dc.contributor.author | Choy, Young Bin | - |
dc.contributor.author | Ahn, June Hong | - |
dc.contributor.author | Lee, Wonhwa | - |
dc.contributor.author | Park, Chun Gwon | - |
dc.date.accessioned | 2023-07-24T09:26:37Z | - |
dc.date.available | 2023-07-24T09:26:37Z | - |
dc.date.created | 2023-07-19 | - |
dc.date.issued | 2021-01 | - |
dc.identifier.issn | 0142-9612 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/187330 | - |
dc.description.abstract | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new strain of coronavirus not previously identified in humans. Globally, the number of confirmed cases and mortality rates of coronavirus disease 2019 (COVID-19) have risen dramatically. Currently, there are no FDA-approved antiviral drugs and there is an urgency to develop treatment strategies that can effectively suppress SARS-CoV-2-mediated cytokine storms, acute respiratory distress syndrome (ARDS), and sepsis. As symptoms progress in patients with SARS-CoV-2 sepsis, elevated amounts of cell-free DNA (cfDNA) are produced, which in turn induce multiple organ failure in these patients. Furthermore, plasma levels of DNase-1 are markedly reduced in SARS-CoV-2 sepsis patients. In this study, we generated recombinant DNase-1-coated polydopamine-poly(ethylene glycol) nanoparticulates (named long-acting DNase-1), and hypothesized that exogenous administration of long-acting DNase-1 may suppress SARS-CoV-2-mediated neutrophil activities and the cytokine storm. Our findings suggest that exogenously administered long-acting nanoparticulate DNase-1 can effectively reduce cfDNA levels and neutrophil activities and may be used as a potential therapeutic intervention for life-threatening SARS-CoV-2-mediated illnesses. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCI LTD | - |
dc.title | Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Hee Ho | - |
dc.identifier.doi | 10.1016/j.biomaterials.2020.120389 | - |
dc.identifier.scopusid | 2-s2.0-85094326875 | - |
dc.identifier.wosid | 000598391300004 | - |
dc.identifier.bibliographicCitation | BIOMATERIALS, v.267, pp.1 - 10 | - |
dc.relation.isPartOf | BIOMATERIALS | - |
dc.citation.title | BIOMATERIALS | - |
dc.citation.volume | 267 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 10 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Engineering | - |
dc.relation.journalResearchArea | Materials Science | - |
dc.relation.journalWebOfScienceCategory | Engineering, Biomedical | - |
dc.relation.journalWebOfScienceCategory | Materials Science, Biomaterials | - |
dc.subject.keywordPlus | EXTRACELLULAR TRAPS | - |
dc.subject.keywordPlus | SEPSIS | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | ADULTS | - |
dc.subject.keywordPlus | DEATH | - |
dc.subject.keywordAuthor | COVID-19 | - |
dc.subject.keywordAuthor | Sepsis | - |
dc.subject.keywordAuthor | DNase | - |
dc.subject.keywordAuthor | Nanoparticles | - |
dc.subject.keywordAuthor | NETosis | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0142961220306359?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.